The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells mTOR阻害剤エベロリムス(RAD001)はPh陽性急性リンパ性白血病静止期細胞のイマチニブ耐性を克服する

Search this Article

Author

    • 鍬塚, 八千代 クワツカ, ヤチヨ

Bibliographic Information

Title

The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells

Other Title

mTOR阻害剤エベロリムス(RAD001)はPh陽性急性リンパ性白血病静止期細胞のイマチニブ耐性を克服する

Author

鍬塚, 八千代

Author(Another name)

クワツカ, ヤチヨ

University

名古屋大学

Types of degree

博士 (医学)

Grant ID

甲第9328号

Degree year

2011-06-30

Note and Description

博士論文

Codes

  • NII Article ID (NAID)
    500000546445
  • NII Author ID (NRID)
    • 8000000548524
  • Text Lang
    • eng
  • NDLBibID
    • 000011300551
  • Source
    • NDL ONLINE

Export

Page Top